Recorded Presentation from Richard Park at PEGS Boston Conference
High quality research. Fast timelines. Within budget. You’re often allowed two out of the three, but what if you could have all three?
A trusted CRO with flexible workflows provides a reliable and supportive structure to build out preclinical research. Over 120,000 successful antibody production runs and a 13+ year history allows evitria AG to help teams rapidly complete preclinical work and use that data to advance.
Subscribe to our Newsletter
Get all the latest updates, and learn about our advancements in antibody production.
Subscribe now
Richard Park, BSc
evitria AG
Global Head, Client Relations & Business Development
Richard leads the Client Relations and Business Development team at evitria AG and joins the conversation with a background in diagnostics and assay development in addition to supporting therapeutic research teams. Richard focuses his efforts on support clients navigate the vast number of options available when exploring or further developing immunoassays and therapies.
Recombinant antibody expression service